Skip to main content

Clinerion is now part of Citeline

| News

Clinerion is now part of Citeline

02.02.2023

Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with regard to drug development acceleration. Clinerion’s headquarters are to remain in Basel.

Clinerion’s CEO Barış Erdoğan has officially announced that the company is now part of Citeline, a leader in clinical trials. The company based in New York, which formerly operated as Pharma Intelligence, merged with Norstella from the US state of Pennsylvania at the end of 2022. This means that the Norstella Group now comprises five companies: Evaluate, MMIT, Panalgo, The Dedham Group, and Citeline.

The new pharmaceutical technology company with more than 1,600 employees across the world is now one of the world’s largest providers of pharma information solutions on the market. According to a press release from Norstella, it is currently valued at 5 billion US dollars. It aims to enable smooth access to life-saving therapies for those with illnesses by accompanying life science companies throughout the entire drug development process.

Clinerion’s headquarters remain in Basel

According to a personal message from Clinerion’s CEO, its integration into Citeline provides the opportunity to access tools and services that each supplement the other’s, thus expanding the product portfolio. Furthermore, Clinerion will gain access to specialists and expertise along the entire process chain from clinical intelligence, planning, development, and studies. This is why the merger with Citeline and the Norstella Group is “excellent news” for partners and customers. Clinerion’s headquarters will remain in Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

Do you have a question? We'd like to hear from you.